BIOLASE Wins FDA Clearance for New Waterlase Use
SAN CLEMENTE, Calif., Feb 25 -- BIOLASE Technology, Inc. has received clearance from the Food and Drug Administration for its patented Waterlase technology for several new bone, periodontal and soft tissue procedures.
The new clearance paves the way for dentists to perform additional procedures with the Waterlase, which is the first laser to receive clearance for these new bone, periodontal and general soft tissue surgical indications:
The clearance also covers soft tissue curettage for post extraction tooth socket. According to the ADA report more than 30 million tooth extractions are performed per year, which can now be treated with the Waterlase.
For further information, visit www.biolase.com
LATEST NEWS
- CLEO Heads to the East Coast
Apr 29, 2024
- Laser-Based Gas Analyzer Developed to Detect Air Pollution
Apr 29, 2024
- Qubits Could be Stored in Flash-Like Memory
Apr 29, 2024
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024